Host: |
Rabbit |
Applications: |
WB, IHC-P, ELISA |
Reactivity: |
Human |
Note: |
FOR RESEARCH USE ONLY (RUO). |
Short Description: |
Rabbit polyclonal antibody Anti-Interferon gamma receptor 1 (101-150 aa, Internal) is suitable for use in Western Blot, Immunohistochemistry and ELISA. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using a epitope-specific immunogen. |
Concentration: |
1 mg/ml |
Dilution Range: |
WB 1:500-1:2000IHC-p 1:100-1:300ELISA 1:20000 |
Storage Instruction: |
Store at-20°C, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
IFNGR1 |
Gene ID: |
3459 |
Uniprot ID: |
INGR1_HUMAN |
Immunogen Region: |
101-150 aa, Internal |
Specificity: |
IFN-gamma R alpha polyclonal antibody detects endogenous levels of IFN-gamma R alpha protein. |
Immunogen: |
Synthesized peptide derived from human IFN-gammaRalpha. |
Function |
Associates with IFNGR2 to form a receptor for the cytokine interferon gamma (IFNG). Ligand binding stimulates activation of the JAK/STAT signaling pathway. Plays an essential role in the IFN-gamma pathway that is required for the cellular response to infectious agents. |
Protein Name |
Interferon Gamma Receptor 1Ifn-Gamma Receptor 1Ifn-Gamma-R1Cdw119Interferon Gamma Receptor Alpha-ChainIfn-Gamma-R-AlphaCd Antigen Cd119 |
Database Links |
Reactome: R-HSA-877300Reactome: R-HSA-877312Reactome: R-HSA-9679191 |
Cellular Localisation |
Cell MembraneSingle-Pass Type I Membrane Protein |
Alternative Antibody Names |
Anti-Interferon Gamma Receptor 1 antibodyAnti-Ifn-Gamma Receptor 1 antibodyAnti-Ifn-Gamma-R1 antibodyAnti-Cdw119 antibodyAnti-Interferon Gamma Receptor Alpha-Chain antibodyAnti-Ifn-Gamma-R-Alpha antibodyAnti-Cd Antigen Cd119 antibodyAnti-IFNGR1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
Source link